Heron Therapeutics
HRTX
$2.45
Share price
-3.92%
Change (1 day)
2.51%
Change (1 year)
Categories
Heron Therapeutics (HRTX) Fails to deliver data
Key failure to deliver metrics for Heron Therapeutics:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.86 M
- Last 3 months FTD volume: $1.71 M
- Last year FTD volume: $11.62 M
Failures to deliver for Heron Therapeutics (HRTX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Heron Therapeutics (HRTX) - since 2014
Volume in USD (price x number of shares), data since 2014Heron Therapeutics (HRTX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $1.71 M | -83.39% |
| 2023 | $10.33 M | -72.07% |
| 2022 | $37 M | 400.43% |
| 2021 | $7.39 M | -54.24% |
| 2020 | $16.15 M | -59.1% |
| 2019 | $39.5 M | 107.62% |
| 2018 | $19.02 M | -26.02% |
| 2017 | $25.71 M | -47.54% |
| 2016 | $49.03 M | 17.09% |
| 2015 | $41.87 M | 1264.2% |
| 2014 | $3.06 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 SurModics SRDX | $0.01 M | $0.4 M | 🇺🇸 USA |
 Pacira Biosciences
PCRX | $1.93 M | $4.86 M | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.58 M | $3.53 M | 🇺🇸 USA |
 Alkermes ALKS | $1.53 M | $34.07 M | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | $0.01 M | $7.04 M | 🇺🇸 USA |